NephroDI Therapeutics - Crunchbase Company Profile & Funding

Q: How much funding has NephroDI Therapeutics raised to date?

NephroDI Therapeutics has raised obfuscated.

Overview

NephroDI Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About NephroDI Therapeutics

CB Rank

51067

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

Founded

obfuscation

Private

Venture - Series Unknown

Philadelphia, Pennsylvania, United States

1-10

nephrodi.com/

Biopharma

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Rachael Hagan: President and CEO
Janet D. Klein: Co-Founder

Details

Legal Name

NephroDI Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Ish Khanna, Janet D. Klein, Jeff M. Sands, Ram Pillarisetti

About the Company

NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney. The company was founded in 2017 by Jeff M. Sands, Janet D. Klein, Ish Khanna, and Ram Pillarisetti and is headquartered in Philadelphia, Pennsylvania.

Phone Number

206-696-0546

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

NephroDI Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

NDI-5001

A preclinical-stage small molecule AMPK activator being developed as a potential therapy for X-linked congenital Nephrogenic Diabetes Insipidus (NDI).

Research & Development

NephroDI Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - NephroDI Therapeutics	—	obfuscated obfuscation	—	Venture - Series Unknown